Recce Pharmaceuticals Ltd. (AU:RCE) has released an update.
Recce Pharmaceuticals Ltd. has fully adhered to the ASX Corporate Governance Council recommendations for the financial year ended 30 June 2024, as detailed in their Corporate Governance Statement. The company’s governance information, including the board charter and details on director appointments, is accessible on their website. This compliance has been officially confirmed in a statement authorized on 30 August 2024 by Company Secretary Maggie Niewidok.
For further insights into AU:RCE stock, check out TipRanks’ Stock Analysis page.
